Viridian Therapeutics Ors Inc (VRDN)
Stock-Based Compensation
$53.61M
TTM · Period ending: · USD
VRDN Stock-Based Compensation
Latest reported$53.61Mperiod ending
Latest reported$53.61Mperiod ending
VRDN TTM Stock-Based Comp ($0.00 → $53.61M)
TTM stock-based compensation
High-resolution chart · PNG
VRDN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 53,613,000 | |
| 47,473,000 | |
| 44,303,000 | |
| 41,289,000 | |
| 38,759,000 | |
| 39,682,000 | |
| 42,150,000 | |
| 59,223,000 | |
| 64,109,000 | |
| 64,644,000 | |
| 67,172,000 | |
| 46,402,000 | |
| 37,739,000 | |
| 30,322,000 | |
| 19,765,000 | |
| 17,978,000 | |
| 17,017,000 | |
| 15,949,000 | |
| 14,465,000 | |
| 12,717,000 | |
| 9,350,000 | |
| 6,156,000 | |
| 3,645,000 | |
| 2,905,000 | |
| 3,164,000 | |
| 3,616,000 | |
| 3,970,000 | |
| 3,904,000 | |
| 3,998,000 | |
| 3,907,000 | |
| 3,679,000 | |
| 3,458,000 | |
| 3,169,000 | |
| 2,780,000 | |
| 2,409,000 | |
| 2,363,000 | |
| 1,777,000 | |
| 1,817,000 | |
| 2,111,000 | |
| 2,198,000 | |
| 2,943,000 | |
| 3,020,000 | |
| 3,015,000 | |
| 2,977,535 | |
| 2,843,260 | |
| 2,131,260 | |
| 1,423,260 | |
| 703,725 | |
| 0 | |
| 0 | |
| 0 |